Размер шрифта
Цветовая схема
Изображения
Форма
Межсимвольный интервал
Межстрочный интервал
стандартные настройки
обычная версия сайта
закрыть
  • Вход
  • Регистрация
  • Помощь
Выбрать БД
Простой поискРасширенный поискИстория поисков
Главная / Результаты поиска
Обзор; СтатьяИскать документыПерейти к записи. 2022; № 7: 60–68. DOI:10.21518/2079-701X-2022-16-7-60-68
Прогностическое и диагностическое значение показателя отношения нейтрофилов к лимфоцитам у пациентов с заболеваниями желудочно-кишечного тракта и печени
Искать документыПерейти к записи[1]
Искать документыПерейти к записи[1]
Аффилированные организации
[1]Искать документыПерейти к записи
Аннотация
Цель данного обзора – провести анализ данных последних научных исследований, оценивающих диагностическую и прогностическую ценность показателя отношения нейтрофилов к лимфоцитам (ОНЛ) у пациентов с заболеваниями желудочно-кишечного тракта (ЖКТ) и печени. У пациентов с неалкогольной жировой болезнью печени (НАЖБП) повышенное значение показателя отношения нейтрофилов к лимфоцитам коррелировало со степенью выраженности фиброза и активностью заболевания, а также позволяло дифференцировать пациентов со стеатозом и неалкогольным стеатогепатитом (НАСГ).  У пациентов с циррозом печени ОНЛ показало свою прогностическую значимость в развитии летального исхода, сопоставимую со шкалами MELD и Child – Pugh, а в некоторых исследованиях даже превосходило их. Противоречивые данные получены в отношении его прогностической ценности в риске развития инфекционных осложнений у данной категории больных. У пациентов с болезнью Крона (БК) и язвенным колитом (ЯК) повышенное значение показателя ОНЛ ассоциировалось  с активностью заболевания. ОНЛ служит предиктором летального исхода и более тяжелого течения острого панкреатита. У пациентов с острым аппендицитом  ОНЛ показало свою диагностическую  значимость в выявлении его  тяжелых форм и прогностическую ценность в развитии летального исхода у пацинтов с онкологическими заболеваниями ЖКТ. ОНЛ служит маркером системного воспаления, который можно рассчитать с помощью параметров простого клинического анализа крови, что доступно в повседневной клинической практике. Ценность ОНЛ обусловлена его неинвазивностью и низкой стоимостью. Анализ литературы показал его прогностическую и диагностическую ценность при определенных заболеваниях ЖКТ и печени: чем выше значение исследуемого показателя, тем хуже прогноз, однако нет единого мнения относительно градации ОНЛ, а уровни отсечения колеблются в различных исследованиях. Также большинство работ носит ретроспективный характер, в связи с чем необходимо проведение крупных проспективных исследований в этом направлении.
Ключевые слова
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Рубрики Mesh
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Искать документыПерейти к записи
Литература

Cupp M., Cariolou M., Tzoulaki I., Aune D., Evangelou E., Berlanga-Taylor A.J. Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies. BMC Med. 2020;18(1):360. https://doi.org/10.1186/s12916-020-01817-1..
DOI: 10.1186/s12916-020-01817-1

Afari M.E., Bhat T. Neutrophil to lymphocyte ratio (NLR) and cardiovascu lar diseases: an update. Expert Rev Cardiovasc Ther. 2016;14(5):573–577. https://doi.org/10.1586/14779072.2016.1154788..
DOI: 10.1586/14779072.2016.1154788

Hao X., Li D., Wu D., Zhang N. The Relationship between Hematological Indices and Autoimmune Rheumatic Diseases (ARDs), a Meta-Analysis. Sci Rep. 2017;7(1):10833. https://doi.org/10.1038/s41598-017-11398-4..
DOI: 10.1038/s41598-017-11398-4

Russell C.D., Parajuli A., Gale H.J., Bulteel N.S., Schuetz P., de Jager C.P.C. et al. The utility of peripheral blood leucocyte ratios as biomarkers in infectious diseases: A systematic review and meta-analysis. J Infect. 2019;78(5):339–348. https://doi.org/10.1016/j.jinf.2019.02.006..
DOI: 10.1016/j.jinf.2019.02.006

Pascual-González Y., López-Sánchez M., Dorca J., Santos S. Defining the role of neutrophil-to-lymphocyte ratio in COPD: a systematic literature review. Int J Chron Obstruct Pulmon Dis. 2018;13:3651–3662. https://doi.org/10.2147/COPD.S178068..
DOI: 10.2147/COPD.S178068

Kuyumcu M.E., Yesil Y., Oztürk Z.A., Kizilarslanoğlu C., Etgül S., Halil M., Arıoğul S. The evaluation of neutrophil-lymphocyte ratio in Alzheimer’s disease. Dement Geriatr Cogn Disord. 2012;34(2):69–74. https://doi.org/10.1159/000341583..
DOI: 10.1159/000341583

D’Amico E., Zanghì A., Romano A., Sciandra M., Palumbo G.A.M., Patti F. The Neutrophil-to-Lymphocyte Ratio is Related to Disease Activity in Relapsing Remitting Multiple Sclerosis. Cells. 2019;8(10):1114. https://doi.org/10.3390/cells8101114..
DOI: 10.3390/cells8101114

Steiner J., Frodl T., Schiltz K., Dobrowolny H., Jacobs R., Fernandes B.S. et al. Innate Immune Cells and C-Reactive Protein in Acute First-Episode Psychosis and Schizophrenia: Relationship to Psychopathology and Treatment. Schizophr Bull. 2020;46(2):363–373. https://doi.org/10.1093/schbul/sbz068..
DOI: 10.1093/schbul/sbz068

Moutchia J., Pokharel P., Kerri A., McGaw K., Uchai S., Nji M., Goodman M. Clinical laboratory parameters associated with severe or critical novel coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. PLoS ONE. 2020;15(10):e0239802. https://doi.org/10.1371/journal.pone.0239802..
DOI: 10.1371/journal.pone.0239802

Ивашкин В.Т., Маевская М.В., Шупелькова Ю.О., Буеверов А.О., Драпкина О.М., Морозова М.А. Диагностика и лечение неалкогольной жировой болезни печени. М.; 2012. 32 с.

Peng Y., Li Y., He Y., Wei Q., Xie Q., Zhang L. et al. The role of neutrophil to lymphocyte ratio for the assessment of liver fibrosis and cirrhosis: a systematic review. Expert Rev Gastroenterol Hepatol. 2018;12(5):503–513. https://doi.org/10.1080/17474124.2018.1463158..
DOI: 10.1080/17474124.2018.1463158

Yilmaz H., Yalcin K.S., Namuslu M., Celik H.T., Sozen M., Inan O. et al. Neutrophil-Lymphocyte Ratio (NLR) Could Be Better Predictor than C-reactive Protein (CRP) for Liver Fibrosis in Non-alcoholic Steatohepatitis (NASH). Ann Clin Lab Sci. 2015;45(3):278–286. Available at: https://pubmed.ncbi.nlm.nih.gov/26116591.https://pubmed.ncbi.nlm.nih.gov/26116591

Yilmaz H., Yalcin K.S., Namuslu M., Celik H.T., Sozen M., Inan O. et al. Neutrophil-Lymphocyte Ratio (NLR) Could Be Better Predictor than C-reactive Protein (CRP) for Liver Fibrosis in Non-alcoholic Steatohepatitis (NASH). Ann Clin Lab Sci. 2015;45(3):278–286. Available at: https://pubmed.ncbi.nlm.nih.gov/26116591.https://pubmed.ncbi.nlm.nih.gov/26116591

Alkhouri N., Morris-Stiff G., Campbell C., Lopez R., Tamimi T.A., Yerian L. et al. Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease. Liver Int. 2012;32(2):297–302. https://doi.org/10.1111/j.1478-3231.2011.02639.x..
DOI: 10.1111/j.1478-3231.2011.02639.x

Wu L., Gao X., Guo Q., Li J., Yao J., Yan K. et al. The role of neutrophils in innate immunity-driven nonalcoholic steatohepatitis: lessons learned and future promise. Hepatol Int. 2020;14(5):652–666. https://doi.org/10.1007/s12072-020-10081-7..
DOI: 10.1007/s12072-020-10081-7

Kamari Y., Shaish A., Vax E., Shemesh S., Kandel-Kfir M., Arbel Y. et al. Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice. J Hepatol. 2011;55(5):1086–1094. https://doi.org/10.1016/j.jhep.2011.01.048..
DOI: 10.1016/j.jhep.2011.01.048

Fujii H., Kawada N. Inflammation and fibrogenesis in steatohepatitis. J Gastroenterol. 2012;47(3):215–225. https://doi.org/10.1007/s00535-012-0527-x..
DOI: 10.1007/s00535-012-0527-x

Tarantino G., Conca P., Pasanisi F., Ariello M., Mastrolia M., Arena A. et al. Could inflammatory markers help diagnose nonalcoholic steatohepatitis? Eur J Gastroenterol Hepatol. 2009;21(5):504–511. https://doi.org/10.1097/MEG.0b013e3283229b40..
DOI: 10.1097/MEG.0b013e3283229b40

Yoneda M., Uchiyama T., Kato S., Endo H., Fujita K., Yoneda K. et al. Plasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH). BMC Gastroenterol. 2008;8:53. https://doi.org/10.1186/1471-230X-8-53..
DOI: 10.1186/1471-230X-8-53

Paterson J.M., Morton N.M., Fievet C., Kenyon C.J., Holmes M.C., Staels B. et al. Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc Natl Acad Sci U S A. 2004;101(18):7088–9703. https://doi.org/10.1073/pnas.0305524101..
DOI: 10.1073/pnas.0305524101

Candia R., Riquelme A., Baudrand R., Carvajal C.A., Morales M., Solís N. et al. Overexpression of 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue and portal hypercortisolism in non-alcoholic fatty liver disease. Liver Int. 2012;32(3):392–399. https://doi.org/10.1111/j.1478-3231.2011.02685.x..
DOI: 10.1111/j.1478-3231.2011.02685.x

Ahmed A., Rabbitt E., Brady T., Brown C., Guest P., Bujalska I.J. et al A switch in hepatic cortisol metabolism across the spectrum of non alcoholic fatty liver disease. PLoS ONE. 2012;7(2):e29531. https://doi.org/10.1371/journal.pone.0029531..
DOI: 10.1371/journal.pone.0029531

Kumar, Abbas, Abui K. Fausto. Robbins and Cotran Pathologic Basis of Disease. 7th ed. New York; 2005.

Liu H., Zhang H., Wan G., Sang Y., Chang Y., Wang X., Zeng H. Neutrophillymphocyte ratio: a novel predictor for short-term prognosis in acute-onchronic hepatitis B liver failure. J Viral Hepat. 2014;21(7):499–507. https://doi.org/10.1111/jvh.12160..
DOI: 10.1111/jvh.12160

Fan Z., EnQiang C., Yao D.L., LiBo Y., Hong L., Lang B. et al. Neutrophil– lymphocyte ratio predicts short term mortality in patients with hepatitis B virus-related acute-on-chronic liver failure treated with an artificial liver support system. PLoS ONE. 2017;12(4):e0175332. https://doi.org/10.1371/journal.pone.0175332..
DOI: 10.1371/journal.pone.0175332

Cai J., Wang K., Han T., Jiang H. Evaluation of prognostic values of inflammation-based makers in patients with HBV-related acute-onchronic liver failure. Medicine (Baltimore). 2018;97(46):e13324. https://doi.org/10.1097/MD.0000000000013324..
DOI: 10.1097/MD.0000000000013324

Lin L., Yang F., Wang Y., Su S., Su Z., Jiang X. et al. Prognostic nomogram incorporating neutrophil-to-lymphocyte ratio for early mortality in decompensated liver cirrhosis. Int Immunopharmacol. 2018;56(3):58–64. https://doi.org/10.1016/j.intimp.2018.01.007..
DOI: 10.1016/j.intimp.2018.01.007

Cai Y.J., Dong J.J., Dong J.Z., Chen Y., Lin Z., Song M. et al. A nomogram for predicting prognostic value of inflammatory response biomarkers in decompensated cirrhotic patients without acute-on-chronic liver failure. Aliment Pharmacol Ther. 2017;45(11):1413–1426. https://doi.org/10.1111/apt.14046..
DOI: 10.1111/apt.14046

Chen L., Lou Y., Chen Y., Yang J. Prognostic value of the neutrophil-to-lymphocyte ratio in patients with acute-on-chronic liver failure. Int J Clin Pract. 2014;68(8):1034–1040. https://doi.org/10.1111/ijcp.12408..
DOI: 10.1111/ijcp.12408

Луньков В.Д., Маевская М.В., Цветаева Е.К., Мендез А.Г., Жаркова М.С., Ткаченко П.Е., Ивашкин В.Т. Отношение нейтрофилов к лимфоцитам как предиктор неблагоприятного исхода у пациентов с декомпенсированным циррозом печени. Российский журнал гастроэнтерологии, гепато­ логии, колопроктологии. 2019;(1):47–61. https://doi.org/10.22416/1382-4376-2019-29-1-47-61..
DOI: 10.22416/1382-4376-2019-29-1-47-61

Wedd J., Bambha K.M., Stotts M., Laskey H., Colmenero J., Gralla J., Biggins S.W. Stage of cirrhosis predicts the risk of liver-related death in patients with low Model for End-Stage Liver Disease scores and cirrhosis awaiting liver transplantation. Liver Transpl. 2014;20(10):1193–1201. https://doi.org/10.1002/lt.23929..
DOI: 10.1002/lt.23929

Biggins S.W., Bambha K. MELD-based liver allocation: who is underserved? Semin Liver Dis. 2006;26(3):211–220. https://doi.org/10.1055/s-2006-947291..
DOI: 10.1055/s-2006-947291

Zhang H., Sun Q., Mao W., Fan J., Ye B. Neutrophil-to-Lymphocyte Ratio Predicts Early Mortality in Patients with HBV-Related Decompensated Cirrhosis. Gastroenterol Res Pract. 2016;2016:4394650. https://doi.org/10.1155/2016/4394650..
DOI: 10.1155/2016/4394650

Biyik M., Ucar R., Solak Y., Gungor G., Polat I., Gaipov A. et al. Blood neutrophil–to-lymphocyte ratio independently predicts survival in patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2013;25(4):435–441. https://doi.org/10.1097/MEG.0b013e32835c2af3..
DOI: 10.1097/MEG.0b013e32835c2af3

Kalra A., Wedd J.P., Bambha K.M., Gralla J., Golden-Mason L., Collins C. et al. Neutrophil-to-lymphocyte ratio correlates with proinflammatory neutrophils and predicts death in low model for end-stage liver disease patients with cirrhosis. Liver Transpl. 2017;23(2):155–165. https://doi.org/10.1002/lt.24702..
DOI: 10.1002/lt.24702

Leithead J.A., Rajoriya N., Gunson B.K., Ferguson J.W. Neutrophil-to-lymphocyte ratio predicts mortality in patients listed for liver transplantation. Liver Int. 2015;35(2):502–509. https://doi.org/10.1111/liv.12688..
DOI: 10.1111/liv.12688

Motomura T., Shirabe K., Mano Y., Muto J., Toshima T., Umemoto Y. et al. Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment. J Hepatol. 2013;58(1):58–64. https://doi.org/10.1016/j.jhep.2012.08.017..
DOI: 10.1016/j.jhep.2012.08.017

Xue T.C., Zhang L., Xie X.Y., Ge N.L., Li L.X., Zhang B.H. et al. Prognostic significance of the neutrophil-to-lymphocyte ratio in primary liver cancer: a meta-analysis. PLoS ONE. 2014;9:e96072. https://doi.org/10.1371/journal.pone.0096072..
DOI: 10.1371/journal.pone.0096072

Zhang M., Zhang Y., Liu L., Prithweeraj M., Xu H., Wu R. et al. Neutrophil-to-Lymphocyte Ratio and Albumin: New Serum Biomarkers to Predict the Prognosis of Male Alcoholic Cirrhosis Patients. Biomed Res Int. 2020;2020:7268459. https://doi.org/10.1155/2020/7268459..
DOI: 10.1155/2020/7268459

Kwon J.H., Jang J.W., Kim Y.W., Lee S.W., Nam S.W., Jaegal D. et al. The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis. BMC Gastroenterol. 2015;15:146. https://doi.org/10.1186/s12876-015-0378-z..
DOI: 10.1186/s12876-015-0378-z

Cai Y.J., Dong J.J., Dong J.Z., Yang N.B., Song M., Wang Y.Q. et al. Neutrophil-lymphocyte ratio predicts hospital-acquired bacterial infections in decompensated cirrhosis. Clin Chim Acta. 2017;469:201–207. https://doi.org/10.1016/j.cca.2017.04.011..
DOI: 10.1016/j.cca.2017.04.011

Thabut D., Massard J., Gangloff A., Carbonell N., Francoz C., Nguyen-Khac E. et al. Model for endstage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure. Hepatology. 2007;46(6):1872–1882. https://doi.org/10.1002/hep.21920..
DOI: 10.1002/hep.21920

Cazzaniga M., Dionigi E., Gobbo G., Fioretti A., Monti V., Salerno F. The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome. J Hepatol. 2009;51(3):475–482. https://doi.org/10.1016/j.jhep.2009.04.017..
DOI: 10.1016/j.jhep.2009.04.017

Dirchwolf M., Ruf A.E. Role of systemic inflammation in cirrhosis: From pathogenesis to prognosis. World J Hepatol. 2015;7(16):1974–1981. https://doi.org/10.4254/wjh.v7.i16.1974..
DOI: 10.4254/wjh.v7.i16.1974

Albillos A., Lario M., Álvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol. 2014;61(6):1385–1396. https://doi.org/10.1016/j.jhep.2014.08.010..
DOI: 10.1016/j.jhep.2014.08.010

Jalan R., Fernandez J., Wiest R., Schnabl B., Moreau R., Angeli P. et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference. J Hepatol. 2013;60(6):1310–1324. https://doi.org/10.1016/j.jhep.2014.01.024..
DOI: 10.1016/j.jhep.2014.01.024

Jalan R., Gines P., Olson J.C., Mookerjee R.P., Moreau R., Garcia-Tsao G. et al. Acute-on chronic liver failure. J Hepatol. 2012;57(6):1336–1348. https://doi.org/10.1016/j.jhep.2012.06.026..
DOI: 10.1016/j.jhep.2012.06.026

Jalan R., Gines P., Olson J.C., Mookerjee R.P., Moreau R., Garcia-Tsao G. et al. Acute-on chronic liver failure. J Hepatol. 2012;57(6):1336–1348. https://doi.org/10.1016/j.jhep.2012.06.026..
DOI: 10.1016/j.jhep.2012.06.026

Bruns T., Zimmermann H.W., Stallmach A. Risk factors and outcome of bacterial infections in cirrhosis. World J Gastroenterol. 2014;20(10):2542–2554. https://doi.org/10.3748/wjg.v20.i10.2542..
DOI: 10.3748/wjg.v20.i10.2542

Attar B.M., Moore C.M., George M., Ion-Nedelcu N., Turbay R., Zachariah A. et al. Procalcitonin, and cytokines document a dynamic inflammatory state in non-infected cirrhotic patients with ascites. World J Gastroenterol. 2014;20(9):2374–2382. https://doi.org/10.3748/wjg.v20.i9.2374..
DOI: 10.3748/wjg.v20.i9.2374

Sipeki N., Antal-Szalmas P., Lakatos P.L., Papp M. Immune dysfunction in cirrhosis. World J Gastroenterol. 2014;20(10):2564–2577. https://doi.org/10.3748/wjg.v20.i10.2564..
DOI: 10.3748/wjg.v20.i10.2564

Tiegs G., Lohse A.W. Immune tolerance: what is unique about the liver. J Autoimmun. 2010;34(1):1–6. https://doi.org/10.1016/j.jaut.2009.08.008..
DOI: 10.1016/j.jaut.2009.08.008

Wasmuth H.E., Kunz D., Yagmur E., Timmer-Stranghöner A., Vidacek D., Siewert E. et al. Patients with acute on chronic liver failure display “sepsis-like” immune paralysis. J Hepatol. 2005;42(2):195–201. https://doi.org/10.1016/j.jhep.2004.10.019..
DOI: 10.1016/j.jhep.2004.10.019

Acarturk G., Acay A., Demir K., Ulu M.S., Ahsen A., Yuksel S. Neutrophil-to-lymphocyte ratio in inflammatory bowel disease – as a new predictor of disease severity. Bratisl Lek Listy. 2015;116(4):213–217. Available at: https://pubmed.ncbi.nlm.nih.gov/25773946.https://pubmed.ncbi.nlm.nih.gov/25773946

Acarturk G., Acay A., Demir K., Ulu M.S., Ahsen A., Yuksel S. Neutrophil-to-lymphocyte ratio in inflammatory bowel disease – as a new predictor of disease severity. Bratisl Lek Listy. 2015;116(4):213–217. Available at: https://pubmed.ncbi.nlm.nih.gov/25773946.https://pubmed.ncbi.nlm.nih.gov/25773946

Gao S.Q., Huang L.D., Dai R.J., Chen D.D., Hu W.J., Shan Y.F. Neutrophil-lymphocyte ratio: a controversial marker in predicting Crohn’s disease severity. Int J Clin Exp Pathol. 2015;8(11):14779–14785. Available at: https://pubmed.ncbi.nlm.nih.gov/26823804.https://pubmed.ncbi.nlm.nih.gov/26823804

Gao S.Q., Huang L.D., Dai R.J., Chen D.D., Hu W.J., Shan Y.F. Neutrophil-lymphocyte ratio: a controversial marker in predicting Crohn’s disease severity. Int J Clin Exp Pathol. 2015;8(11):14779–14785. Available at: https://pubmed.ncbi.nlm.nih.gov/26823804.https://pubmed.ncbi.nlm.nih.gov/26823804

Kang W.M., Zhu C.Z., Yang X.X., Yu J.C., Ma Z.Q., Ye X. et al. Application of the Onodera prognostic nutrition index and neutrophil-to-lymphocyte ratio in risk evaluation of postoperative complications in Crohn’s disease. Sci Rep. 2017;7(1):8481. https://doi.org/10.1038/s41598-017-09265-3..
DOI: 10.1038/s41598-017-09265-3

Argeny S., Stift A., Bergmann M., Mittlböck M., Maschke S., Yang Y. et al. Prognostic value of preoperative neutrophil-to-lymphocyte ratio in Crohn’s disease. Wien Klin Wochenschr. 2018;130(11–12):398–403. https://doi.org/10.1007/s00508-018-1322-3..
DOI: 10.1007/s00508-018-1322-3

Posul E., Yilmaz B., Aktas G., Kurt M. Does neutrophil-tolymphocyte ratio-predict active ulcerative colitis? Wien Klin Wochenschr. 2015;127(7–8):262–265. https://doi.org/10.1007/s00508-014-0683-5..
DOI: 10.1007/s00508-014-0683-5

Celikbilek M., Dogan S., Ozbakir O., Zararsız G., Kücük H., Gürsoy S. et al. Neutrophil-lymphocyte ratio as a predictor of disease severity in ulcerative colitis. J Clin Lab Anal. 2013;27(1):72–76. https://doi.org/10.1002/jcla.21564..
DOI: 10.1002/jcla.21564

Demir A.K., Demirtas A., Kaya S.U., Tastan I., Butun I., Sagcan M. et al. The relationship between the neutrophil-lymphocyte ratio and disease activity in patients with ulcerative colitis. Kaohsiung J Med Sci. 2015;31(11):585–590. https://doi.org/10.1016/j.kjms.2015.10.001..
DOI: 10.1016/j.kjms.2015.10.001

Torun S., Tunc B.D., Suvak B., Yildiz H., Tas A., Sayilir A. et al. Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: a promising marker in predicting disease severity. Clin Res Hepatol Gastroenterol. 2012;36(5):491–497. https://doi.org/10.1016/j.clinre.2012.06.004..
DOI: 10.1016/j.clinre.2012.06.004

Nishida Y., Hosomi S., Yamagami H., Yukawa T., Otani K., Nagami Y. et al. Neutrophil-to-Lymphocyte Ratio for Predicting Loss of Response to Infliximab in Ulcerative Colitis. PLoS ONE. 2017;12(1):e0169845. https://doi.org/10.1371/journal.pone.0169845..
DOI: 10.1371/journal.pone.0169845

Qin X. Etiology of inflammatory bowel disease: A unified hypothesis. World J Gastroenterol. 2012;18(15):1708–1722. https://doi.org/10.3748/wjg.v18.i15.1708..
DOI: 10.3748/wjg.v18.i15.1708

Selby W.S., Janossy G., Bofill M., Jewell D.P. Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques. Gut. 1984;25(1):32–40. https://doi.org/10.1136/gut.25.1.32..
DOI: 10.1136/gut.25.1.32

Pavlidis T.E., Pavlidis E.T., Sakantamis A.K. Advances in prognostic factors in acute pancreatitis: a mini-review. Hepatobiliary Pancreat Dis Int. 2010;9(5):482–486. Available at: https://pubmed.ncbi.nlm.nih.gov/20943456.https://pubmed.ncbi.nlm.nih.gov/20943456

Pavlidis T.E., Pavlidis E.T., Sakantamis A.K. Advances in prognostic factors in acute pancreatitis: a mini-review. Hepatobiliary Pancreat Dis Int. 2010;9(5):482–486. Available at: https://pubmed.ncbi.nlm.nih.gov/20943456.https://pubmed.ncbi.nlm.nih.gov/20943456

Suppiah A., Malde D., Arab T., Hamed M., Allgar V., Smith A.M., Morris-Stiff G. The prognostic value of the neutrophil-lymphocyte ratio (NLR) in acute pancreatitis: identification of an optimal NLR. J Gastrointest Surg. 2013;17(4):675–681. https://doi.org/10.1007/s11605-012-2121-1..
DOI: 10.1007/s11605-012-2121-1

Gülen B., Sonmez E., Yaylacı S., Serinken M., Eken C., Dur A. et al. Effect of harmless acute pancreatitis score, red cell distribution width and neutrophil to lymphocyte ratio on the mortality of patients with nontraumatic acute pancreatitis at the emergency department. World J Emerg Med. 2015;6(1):29–33. https://doi.org/10.5847/wjem.j.1920-8642.2015.01.005..
DOI: 10.5847/wjem.j.1920-8642.2015.01.005

Zhang Y., Wu W., Dong L., Yang C., Fan P., Wu H. Neutrophil to lymphocyte ratio predicts persistent organ failure and in-hospital mortality in an Asian Chinese population of acute pancreatitis. Medicine (Baltimore). 2016;95(37):e4746. https://doi.org/10.1097/MD.0000000000004746..
DOI: 10.1097/MD.0000000000004746

Kokulu K., Günaydın Y.K., Akıllı N.B., Köylü R., Sert E.T., Köylü Ö., Cander B. Relationship between the neutrophil-to-lymphocyte ratio in acute pancreatitis and the severity and systemic complications of the disease. Turk J Gastroenterol. 2018;29(6):684–691. https://doi.org/10.5152/tjg.2018.17563..
DOI: 10.5152/tjg.2018.17563

Jeon T.J., Park J.Y. Clinical significance of the neutrophil-lymphocyte ratio as an early predictive marker for adverse outcomes in patients with acute pancreatitis. World J Gastroenterol. 2017;23(21):3883–3889. https://doi.org/10.3748/wjg.v23.i21.3883..
DOI: 10.3748/wjg.v23.i21.3883

Felderbauer P., Muller C., Bulut K., Belyaev O., Schmitz F., Uhl W. et al. Pathophysiology and treatment of acute pancreatitis: new therapeutic targets-a ray of hope? Basic Clin Pharmacol Toxicol. 2005;97(6):342–350. https://doi.org/10.1111/j.1742-7843.2005.pto_274.x..
DOI: 10.1111/j.1742-7843.2005.pto_274.x

Wittel U.A., Rau B., Gansauge F., Gansauge S., Nussler A.K., Beger H.G., Poch B. Influence of PMN leukocyte-mediated pancreatic damage on the systemic immune response in severe acute pancreatitis in rats. Dig Dis Sci. 2004;49(7–8): 1348–1357. https://doi.org/10.1023/b:ddas.0000037833.16433.77..
DOI: 10.1023/b:ddas.0000037833.16433.77

De Jager C.P., van Wijk P.T., Mathoera R.B., de Jongh-Leuvenink J., van der Poll T., Wever P.C. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care. 2010;14(5):R192. https://doi.org/10.1186/cc9309..
DOI: 10.1186/cc9309

Zahorec R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102(1):5–14. Available at: https://pubmed.ncbi.nlm.nih.gov/11723675.https://pubmed.ncbi.nlm.nih.gov/11723675

Zahorec R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102(1):5–14. Available at: https://pubmed.ncbi.nlm.nih.gov/11723675.https://pubmed.ncbi.nlm.nih.gov/11723675

Le Tulzo Y., Pangault C., Gacouin A., Guilloux V., Tribut O., Amiot L. et al. Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock. 2002;18(6):487–494. https://doi.org/10.1097/00024382-200212000-00001..
DOI: 10.1097/00024382-200212000-00001

Pavlov P., Uchikov P., Murdzheva M., Tuleva S., Tsvetkova T. Main lymphocyte populations and their subpopulations in patients with acute pancreatitis studied in the course of disease. Khirurgiia (Sofiia). 2001;57(5–6):4–11. Available at: https://pubmed.ncbi.nlm.nih.gov/12122758.https://pubmed.ncbi.nlm.nih.gov/12122758

Pavlov P., Uchikov P., Murdzheva M., Tuleva S., Tsvetkova T. Main lymphocyte populations and their subpopulations in patients with acute pancreatitis studied in the course of disease. Khirurgiia (Sofiia). 2001;57(5–6):4–11. Available at: https://pubmed.ncbi.nlm.nih.gov/12122758.https://pubmed.ncbi.nlm.nih.gov/12122758

Pezzilli R., Billi P., Beltrandi E., Maldini M., Mancini R., Morselli Labate A.M., Miglioli M. Circulating lymphocyte subsets in human acute pancreatitis. Pancreas. 1995;11(1):95–100. https://doi.org/10.1097/00006676-199507000-00010..
DOI: 10.1097/00006676-199507000-00010

Goodman D.A., Goodman C.B., Monk J.S. Use of the neutrophil:lymphocyte ratio in the diagnosis of appendicitis. Am Surg. 1995;61(3):257–259. Available at: https://pubmed.ncbi.nlm.nih.gov/7887542.https://pubmed.ncbi.nlm.nih.gov/7887542

Goodman D.A., Goodman C.B., Monk J.S. Use of the neutrophil:lymphocyte ratio in the diagnosis of appendicitis. Am Surg. 1995;61(3):257–259. Available at: https://pubmed.ncbi.nlm.nih.gov/7887542.https://pubmed.ncbi.nlm.nih.gov/7887542

Markar S.R., Karthikesalingam A., Falzon A., Kan Y. The diagnostic value of neutrophil: lymphocyte ratio in adults with suspected acute appendicitis. Acta Chir Belg. 2010;110:543–547. Available at: https://pubmed.ncbi.nlm.nih.gov/21158332.https://pubmed.ncbi.nlm.nih.gov/21158332

Markar S.R., Karthikesalingam A., Falzon A., Kan Y. The diagnostic value of neutrophil: lymphocyte ratio in adults with suspected acute appendicitis. Acta Chir Belg. 2010;110:543–547. Available at: https://pubmed.ncbi.nlm.nih.gov/21158332.https://pubmed.ncbi.nlm.nih.gov/21158332

Ishizuka M., Shimizu T., Kubota K. Neutrophil-to-lymphocyte ratio has a close association with gangrenous appendicitis in patients undergoing appendectomy. Int Surg. 2012;97(4):299–304. https://doi.org/10.9738/CC161.1..
DOI: 10.9738/CC161.1

Kahramanca Ş., Özgehan G., Şeker D., Gökce E.I., Seker G., Tunç G. et al. Neutrophil-to-lymphocyte ratio as a predictor of acute appendicitis. Ulus Travma Acil Cerrahi Derg. 2014;20(1):19–22. https://doi.org/10.5505/tjtes.2014.20688..
DOI: 10.5505/tjtes.2014.20688

Kucuk A., Erol M.F., Senel S., Eroler E., Yumun H.A., Uslu A.U. et al. The role of neutrophil lymphocyte ratio to leverage the differential diagnosis of familial Mediterranean fever attack and acute appendicitis. Korean J Intern Med. 2016;31(2):386–391. https://doi.org/10.3904/kjim.2015.039..
DOI: 10.3904/kjim.2015.039

Bowen R.C., Little N.A.B., Harmer J.R., Ma J., Mirabelli L.G., Roller K.D. et al. Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis. Oncotarget. 2017;8(19):32171–32189. https://doi.org/10.18632/oncotarget16291..
DOI: 10.18632/oncotarget16291

Templeton A.J., McNamara M.G., Seruga B., Vera-Badillo F.E., Aneja P., Ocaña A. et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106(6):dju124. https://doi.org/10.1093/jnci/dju124..
DOI: 10.1093/jnci/dju124

Nora I., Shridhar R., Huston J., Meredith K. The accuracy of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as a marker for gastrointestinal malignancies. J Gastrointest Oncol. 2018;9(5):972–978. https://doi.org/10.21037/jgo.2018.08.05..
DOI: 10.21037/jgo.2018.08.05

Kitamura T., Qian B.Z., Pollard J.W. Immune cell promotion of metastasis. Nat Rev Immunol. 2015;15(2):73–86. https://doi.org/10.1038/nri3789..
DOI: 10.1038/nri3789

Karki R., Man S.M., Kanneganti T.D. Inflammasomes and Cancer. Cancer Immunol Res. 2017;5(2):94 –99. https://doi.org/10.1158/2326-6066.CIR-16-0269..
DOI: 10.1158/2326-6066.CIR-16-0269

Fridlender Z.G., Albelda S.M. Tumor-associated neutrophils: friend or foe? Carcinogenesis. 2012;33(5):949– 955. https://doi.org/10.1093/carcin/bgs123..
DOI: 10.1093/carcin/bgs123

Singhal S., Bhojnagarwala P.S., O’Brien S., Moon E.K., Garfall A.L., Rao A.S. et al. Origin and role of a subset of tumor-associated neutrophils with antigen-presenting cell features in early-stage human lung cancer. Cancer Cell. 2016;30(1):120–135. https://doi.org/10.1016/j.ccell.2016.06.001..
DOI: 10.1016/j.ccell.2016.06.001

Долгушин И.И. Нейтрофильные гранулоциты: новые лица старых знакомых. Бюллетень сибирской медицины. 2019;(1):30–37. https://doi.org/10.20538/1682-0363-2019-1-30-37..
DOI: 10.20538/1682-0363-2019-1-30-37

Nicolás-Ávila J.Á., Adrover J.M., Hidalgo A. Neutrophils in homeostasis, immunity, and cancer. Immunity. 2017;46(1):15–28. https://doi.org/10.1016/j.immuni.2016.12.012..
DOI: 10.1016/j.immuni.2016.12.012

Powell D.R., Huttenlocher A. Neu-trophils in the tumor microenvironment. Trends Immunol. 2016;37(1):41–52. https://doi.org/10.1016/j.it.2015.11.008..
DOI: 10.1016/j.it.2015.11.008

Shaul M.E., Fridlender Z.G. Cancer related circulating and tumor-associated neutrophils – subtypes, sources and function. FEBS J. 2018;285(23):4316–4342. https://doi.org/10.1111/febs.14524..
DOI: 10.1111/febs.14524

Дополнительная информация
Язык текста: Русский
ISSN: 2079-701X
Унифицированный идентификатор ресурса для цитирования: //medj.rucml.ru/journal/4e432d4d4544534f5645542d41525449434c452d323032322d302d372d302d36302d3638/